Patents by Inventor Paul Nghiem

Paul Nghiem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240226257
    Abstract: Antibodies that bind the tumor (T) antigen of the Merkel cell polyomavirus are disclosed. The antibodies can be use used in cell-based immunotherapies, antibody-based therapies, diagnostics, and detection assays, among other uses.
    Type: Application
    Filed: October 23, 2023
    Publication date: July 11, 2024
    Applicants: Fred Hutchinson Cancer Center, University of Washington
    Inventors: Justin J. Taylor, Denise Galloway, Paul Nghiem, David Koelle, Haroldo Rodriguez, Joseph Carter
  • Publication number: 20240131132
    Abstract: Antibodies that bind the tumor (T) antigen of the Merkel cell polyomavirus are disclosed. The antibodies can be use used in cell-based immunotherapies, antibody-based therapies, diagnostics, and detection assays, among other uses.
    Type: Application
    Filed: October 22, 2023
    Publication date: April 25, 2024
    Applicants: Fred Hutchinson Cancer Center, University of Washington
    Inventors: Justin J. Taylor, Denise Galloway, Paul Nghiem, David Koelle, Haroldo Rodriguez, Joseph Carter
  • Publication number: 20210252057
    Abstract: The present disclosure provides binding proteins and TCRs with high affinity and specificity against Merkel cell polyomavirus T antigen epitopes or peptides, T cells expressing such high affinity Merkel cell polyomavirus T antigen specific TCRs, nucleic acids encoding the same, and compositions for use in treating Merkel cell carcinoma.
    Type: Application
    Filed: May 15, 2019
    Publication date: August 19, 2021
    Inventors: Aude CHAPUIS, Paul NGHIEM, Megan MCAFEE, Natalie MILLER, Kelly PAULSON, David KOELLE, Thomas SCHMITT, Candice CHURCH
  • Publication number: 20050276765
    Abstract: Disclosed is, inter alia, a method of reducing UVB-induced wrinkles in a subject, the method that includes: administering to a subject having, or at risk for, UVB-induced wrinkle, a composition comprising an agent that inhibits ATR mediated signaling.
    Type: Application
    Filed: June 9, 2005
    Publication date: December 15, 2005
    Inventors: Paul Nghiem, Seishiro Fujii